SEA Medical Addresses Hospital Drug Administration Errors
SEA Medical Systems is a medical devices company that has developed an innovative technology to address a serious health care practice complication, the erroneous administration […]
SEA Medical Systems is a medical devices company that has developed an innovative technology to address a serious health care practice complication, the erroneous administration […]
“The Provider as a System” will discuss how innovations in information management and technology coupled with changes in the business landscape are transforming the delivery of healthcare.
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
A recent study commissioned by the Society of Actuaries and completed by Milliman, Inc., highlighted both the high personal and financial costs exacted by measurable medical errors.
The OneMedForum was recognized by Michael R. Bloomberg, Mayor of New York City, as an important event supporting innovation in the healthcare and life science industries.
The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
Medication error is one of the top 10 causes of death in the United States, killing an estimated 7,000 people per year.
Intravenous (IV) drugs leave a huge margin for human error, particularly at the point of administration.
Michael Weickert, President and CEO of SEA Medical Systems, Inc., discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Michael Weickert, President and CEO of SEA Medical Systems, Inc., discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Copyright © 2024 | WordPress Theme by MH Themes